BlackRock Health Sciences Opportunities Portfolio Investor C Shares SHSCX

Morningstar Medalist Rating
  • NAV / 1-Day Return $49.51  /  −0.22 %
  • Fund Size $6.4B
  • Adjusted Expense Ratio 1.900%
  • Net Expense Ratio 1.890%
  • Fee Level: Distribution Below Average
  • Share Class Type Level Load
  • Morningstar Category Health
  • Equity Style Box (Funds) Large Value
  • Minimum Initial Investment $1,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 49%

Morningstar’s Analysis SHSCX

Will SHSCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Inv C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 54.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.13 760M
Healthcare

Johnson & Johnson

8.13 510M
Healthcare

Merck & Co Inc

5.57 349M
Healthcare

AbbVie Inc

5.27 330M
Healthcare

Thermo Fisher Scientific Inc

4.91 308M
Healthcare

Gilead Sciences Inc

4.24 266M
Healthcare

Amgen Inc

3.97 249M
Healthcare

UnitedHealth Group Inc

3.89 244M
Healthcare

Danaher Corp

3.50 219M
Healthcare

Vertex Pharmaceuticals Inc

3.26 204M
Healthcare

Sponsor Center